Please try another search
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Kenneth M. Bate | 73 | 2014 | Independent Chairman of the Board |
Jill C. Milne | 55 | 2008 | Co-Founder, CEO, President & Director |
Jonathan Violin | 48 | 2021 | Independent Director |
Hugh M. Cole | 58 | 2019 | Independent Director |
Frederick Peter Callori | 55 | 2021 | Independent Director |
Gregory Anthony Lapointe | 64 | 2019 | Independent Director |
Jay D. Horton | - | - | Member of Scientific Advisory Board |
Joanne T. Beck | 61 | 2019 | Independent Director |
Johannes Jacob Pieter Kastelein | 69 | - | Member of Scientific Advisory Board |
Steven E. Shoelson | - | - | Member of Scientific Advisory Board |
Roger Ulrich | - | - | Member of Scientific Advisory Board |
Michael Jirousek | 64 | 2008 | Member of Scientific Advisory Board |
Sekar Kathiresan | 51 | - | Member of Scientific Advisory Board |
Edward M. Scolnick | 82 | - | Member of Scientific Advisory Board |
Michael D. Kishbauch | 74 | 2016 | Independent Director |
Arthur H. Rubenstein | 86 | - | Member of Scientific Advisory Board |
Sunil Agarwal | 54 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review